Arima Hitoshi
Graduate School of Urban Social and Cultural Studies, Yokohama City University, Kanazawa-Ku, Seto 22-2, Yokohama, Japan.
Theor Med Bioeth. 2025 Jun;46(3):209-230. doi: 10.1007/s11017-025-09712-7. Epub 2025 Mar 21.
It is often believed that withholding or withdrawing life-sustaining treatment is justifiable only when the patient's death is not intended. Also, in accordance with this belief, many argue that the justification of withholding/withdrawing life-sustaining treatment is an application of the doctrine of double effect (hereafter DDE). This paper aims to defend these accounts from some important criticisms. Baruch Brody maintains that most people intend the patient's death when they withhold/withdraw such treatments and that therefore, there are many cases of withholding/withdrawing treatment that are clearly justifiable but rendered unjustifiable by the accounts. Daniel P. Sulmasy asserts that withholding/withdrawing treatment rarely satisfies DDE's fourth condition (that the good effect of the act is proportionately greater than its bad effect) because the goodness of avoiding treatment burden seldom compares to the badness of shortening life. I examine these claims and show that they are mistaken. Central to the discussion in this paper is the idea that those who withhold/withdraw life-sustaining treatment often only intend to avoid the burdens posed by the treatment itself and not to shorten the patient's life. It will be argued that both Brody and Sulmasy are led to an erroneous conclusion because they fail to have an accurate understanding of this idea and its implications.
人们常常认为,只有在不意图导致患者死亡的情况下,停止或撤销维持生命的治疗才是合理的。同样,基于这种观点,许多人认为停止/撤销维持生命的治疗的合理性是双重效果原则(以下简称DDE)的应用。本文旨在为这些观点辩护,使其免受一些重要批评。巴鲁克·布罗迪认为,大多数人在停止/撤销此类治疗时意图导致患者死亡,因此,存在许多停止/撤销治疗的情况,这些情况显然是合理的,但根据这些观点却变得不合理。丹尼尔·P·苏尔马西断言,停止/撤销治疗很少满足DDE的第四个条件(即该行为的良好效果在比例上大于其不良效果),因为避免治疗负担的好处很少能与缩短生命的坏处相比较。我审视了这些说法,并表明它们是错误的。本文讨论的核心观点是,那些停止/撤销维持生命治疗的人通常只意图避免治疗本身带来的负担,而不是缩短患者的生命。将论证布罗迪和苏尔马西都得出了错误的结论,因为他们未能准确理解这一观点及其含义。